User profiles for K. Vardakas

Konstantinos Z. Vardakas

Henry Dunant Hospital, Athens, Greece
Verified email at aibs.gr
Cited by 10250

Fosfomycin

…, G Samonis, KZ Vardakas - Clinical microbiology …, 2016 - Am Soc Microbiol
The treatment of bacterial infections suffers from two major problems: spread of multidrug-resistant
(MDR) or extensively drug-resistant (XDR) pathogens and lack of development of …

[HTML][HTML] Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

…, DE Karageorgopoulos, KZ Vardakas - Emerging infectious …, 2014 - ncbi.nlm.nih.gov
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae
by using studies from around the world published before April 9, 2012. Attributable death …

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli, PI Rafailidis… - Journal of …, 2012 - academic.oup.com
… coli and K. pneumoniae were the most frequently studied pathogens. … coli or K. pneumoniae
were too limited to allow for meaningful comparisons as the authors either studied a small …

[HTML][HTML] Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a …

ME Falagas, N Roussos, KZ Vardakas - International Journal of Infectious …, 2010 - Elsevier
BACKGROUND: Candidemia is among the leading causes of nosocomial bloodstream
infections and is associated with significant mortality. Several centers have published data …

[HTML][HTML] Sex differences in the incidence and severity of respiratory tract infections

ME Falagas, EG Mourtzoukou, KZ Vardakas - Respiratory medicine, 2007 - Elsevier
Sex is a significant epidemiological factor for several diseases. However, the role of sex in
the development and outcome of various infections has not been extensively studied with the …

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

…, GS Tansarli, K Ikawa, KZ Vardakas - Clinical infectious …, 2013 - academic.oup.com
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is longer, …

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence

KZ Vardakas, KA Polyzos, K Patouni… - International journal of …, 2012 - Elsevier
The objective of this review was to evaluate the frequency of treatment failure and recurrence
of Clostridium difficile infection (CDI) following treatment with vancomycin or metronidazole …

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials

KZ Vardakas, GL Voulgaris, A Maliaros… - The Lancet infectious …, 2018 - thelancet.com
Background The findings of randomised controlled trials (RCT), observational studies, and
meta-analyses vary regarding the effectiveness of prolonged β-lactam infusion. We aimed to …

Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of …

IA Bliziotis, G Samonis, KZ Vardakas… - Clinical infectious …, 2005 - academic.oup.com
Background . The addition of an aminoglycoside to a β-lactam therapy regimen has been
suggested to have a beneficial effect in delaying or preventing the development of …

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

ME Falagas, II Siempos, KZ Vardakas - The Lancet infectious …, 2008 - thelancet.com
Linezolid has been approved for the treatment of patients with infections caused by Gram-positive
cocci that are resistant to traditionally used antibiotics, including glycopeptides. This …